Transcriptomic signatures of exacerbated progression in leptospirosis subclinical chronic kidney disease with secondary nephrotoxic injury
Authors:
- 1 May 2021
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 320 (5) , F1001-F1018
Abstract
Leptospira-infected mice followed by secondary nephrotoxic injury exacerbated immune/inflammatory responses and renal fibrosis. Comparison with the murine model revealed candidates involved in the progression of renal fibrosis in chronic kidney disease (CKD). Comparative transcriptome study suggests that secondary nephrotoxic injury in Leptospira-infected mice recapitulates the gene expression signatures found in CKD patients. This study indicates that secondary nephrotoxic injury may exacerbate CKD in chronic Leptospira infection implicating in the progression of CKD of unknown etiology.Keywords
This publication has 74 references indexed in Scilit:
- CKD of Unknown Etiology (CKDu) in Sri Lanka: A Multilevel Clinical Case Definition for Surveillance and Epidemiological StudiesKidney International Reports, 2019
- CKD Hotspots: Challenges and Areas of OpportunitySeminars in Nephrology, 2019
- High Prevalence of CKD of Unknown Etiology in Uddanam, IndiaKidney International Reports, 2019
- AKI on CKD: heightened injury, suppressed repair, and the underlying mechanismsKidney International, 2017
- CKD of Uncertain EtiologyClinical Journal of the American Society of Nephrology, 2016
- Mesoamerican nephropathy: a neglected tropical disease with an infectious etiology?Microbes and Infection, 2015
- Global dimensions of chronic kidney disease of unknown etiology (CKDu): a modern era environmental and/or occupational nephropathy?BMC Nephrology, 2015
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Acute kidney injury and chronic kidney disease: an integrated clinical syndromeKidney International, 2012
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005